Wolverine Trading’s IGM Biosciences IGMS Stock Holding History

Wolverine Trading’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,200	Closed	-$213K	–	6314
2021 Q3	$213K	Buy	+3,200	New	+$245K	﹤0.01%	5242

Other funds holding IGMS

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wolverine Trading's IGMS Position: Q4 2021 in Review

Wolverine Trading sold out of IGM Biosciences (IGMS) in Q4 2021, closing a stake of 4,160 shares — an estimated $276K sold.

Wolverine Trading first reported a position in IGMS in Q3 2021 and held it in 1 quarter. The position peaked at $276K in Q3 2021. 87 funds tracked by Wall St. Rank hold IGMS as of Q4 2021.

Wolverine Trading reported no remaining IGM Biosciences position as of Q4 2021 after selling out during the quarter.
Wolverine Trading sold 4,160 IGM Biosciences shares in Q4 2021, an estimated $276K.
Wolverine Trading first reported a position in IGM Biosciences in Q3 2021 and held it in 1 quarter.
Wolverine Trading's IGM Biosciences position peaked at $276K in Q3 2021.
87 funds tracked by Wall St. Rank held IGM Biosciences as of Q4 2021.

Based on Wolverine Trading's 13F filing for Q4 2021, filed 14 Feb 2022.